Gruss Capital Management LP Trimmed Synchrony Finl (SYF) Holding; Ampliphi Biosciences (TGEN)’s Sentiment Is 4.5

September 11, 2017 - By Adrian Erickson

Tecogen Inc. designs, manufactures, sells and maintains cogeneration products, including combined heat and power , air conditioning systems and water heaters for residential, commercial, recreational and industrial use. The company has market cap of $83.77 million. The Firm is engaged in the business of manufacturing and supporting CHP products based on engines fueled by natural gas. It has a 327890 P/E ratio. The Firm makes over three types of CHP products, such as cogeneration units that supply electricity and hot water, chillers that provide air-conditioning and hot water, and water heaters.

Gruss Capital Management Lp decreased Synchrony Finl (SYF) stake by 62.29% reported in 2016Q4 SEC filing. Gruss Capital Management Lp sold 937,500 shares as Synchrony Finl (SYF)’s stock declined 26.83%. The Gruss Capital Management Lp holds 567,500 shares with $20.58M value, down from 1.51 million last quarter. Synchrony Finl now has $23.25 billion valuation. The stock rose 2.40% or $0.69 reaching $29.24. About 3.19M shares traded. Synchrony Financial (NYSE:SYF) has declined 10.35% since September 11, 2016 and is downtrending. It has underperformed by 27.05% the S&P500.

Bard Associates Inc holds 1.13% of its portfolio in Tecogen Inc for 578,600 shares. Clear Harbor Asset Management Llc owns 659,913 shares or 0.58% of their US portfolio. Moreover, Parsons Capital Management Inc Ri has 0.02% invested in the company for 37,500 shares. The California-based Blackrock Fund Advisors has invested 0% in the stock. Blackrock Investment Management Llc, a New Jersey-based fund reported 1,947 shares.

About 8,485 shares traded. Tecogen Inc (TGEN) has declined 4.09% since September 11, 2016 and is downtrending. It has underperformed by 20.79% the S&P500.